Abstract
P-276 Healthcare resource utilization and costs among patients with relapsed/refractory multiple myeloma treated with chimeric antigen receptor-T (CAR-T) cell therapy
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
